Results 41 to 50 of about 11,970,410 (409)
Respiratory Research, 2021 Background A common variant located in the promoter region of MUC5B (rs35705950) is the strongest risk factor for sporadic and familiar IPF, as well as a predictor of outcome.
Davide Biondini +12 more
doaj +1 more source
Cells, 2023 Monocytes play a vital role in the development of cardiovascular diseases. Type 2 diabetes mellitus (T2DM) is a major CVD risk factor, and T2DM-induced aberrant activation and enhanced migration of monocytes is a vital pathomechanism that leads to ...
Marc Dorenkamp +7 more
doaj +1 more source
BMJ Open, 2020 Introduction Leg ulcers (LUs) not only seriously affect life and work of patients, but also bring huge economic burden to the society. As a potential underused biological debridement, larval therapy provides help for the treatment of LUs.
Xiao Yang +5 more
doaj +1 more source
Osteopontin in Vascular Disease: Friend or Foe?
Arteriosclerosis, Thrombosis and Vascular Biology, 2019 Inflammatory cytokines are necessary for an acute response to injury and the progressive healing process. However, when this acute response does not resolve and becomes chronic, the same proteins that once promoted healing then contribute to chronic ...
Zoe S Lok, A. Lyle
semanticscholar +1 more source
Vascular Diseases and Gangliosides [PDF]
International Journal of Molecular Sciences, 2019 Vascular diseases, such as myocardial infarction and cerebral infarction, are most commonly caused by atherosclerosis, one of the leading causes of death worldwide. Risk factors for atherosclerosis include lifestyle and aging. It has been reported that lifespan could be extended in mice by targeting senescent cells, which led to the suppression of ...
Norihiko Sasaki, Masashi Toyoda
openaire +2 more sources
Interactive effects of vascular risk burden and advanced age on cerebral blood flow. [PDF]
, 2014 Vascular risk factors and cerebral blood flow (CBF) reduction have been linked to increased risk of cognitive impairment and Alzheimer's disease (AD); however the possible moderating effects of age and vascular risk burden on CBF in late life remain ...
Bangen, Katherine J +10 more
core +1 more source
Inhaled Nanoparticles Accumulate at Sites of Vascular Disease
ACS Nano, 2017 The development of engineered nanomaterials is growing exponentially, despite concerns over their potential similarities to environmental nanoparticles that are associated with significant cardiorespiratory morbidity and mortality. The mechanisms through
Mark R. Miller +17 more
semanticscholar +1 more source
A cross-sectional study of vascular risk factors in a rural South African population : data from the Southern African Stroke Prevention Initiative (SASPI) [PDF]
, 2007 Background: Rural sub-Saharan Africa is at an early stage of economic and health transition. It is predicted that the 21st century will see a serious added economic burden from non-communicable disease including vascular disease in low-income countries
A Lee +48 more
core +3 more sources
Circulation, 2011 Since the 2006 update of the American Heart Association (AHA)/American College of Cardiology Foundation (ACCF) guidelines on secondary prevention,1 important evidence from clinical trials has emerged that further supports and broadens the merits of ...
Sidney C. Smith +17 more
semanticscholar +1 more source
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms [PDF]
Canadian Journal of Cardiology, 2017 Hypertension and type 2 diabetes are common comorbidities. Hypertension is twice as frequent in patients with diabetes compared with those who do not have diabetes.
J. Petrie, T. Guzik, R. Touyz
semanticscholar +3 more sources